Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Nasopharyngeal Cancinoma (NPC)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Dongguan People's Hospital, Dongguan, Guangdong, China
Contact: Study coordinator (Zhi-Gang Liu, Dr.) · zhigangliu1983@hotmail.com · +8613712645531
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Contact: Study coordinator (Hai-Qiang Mai, Dr.) · maihq@sysucc.org.cn · +8602087343380
Contact: Study coordinator (Li-Ting Liu, Dr.) · liult@sysucc.org.cn · +8602087343380
Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen, Shenzhen, Guangdong, China
Contact: Study coordinator (Jiang-Hu Zhang, Dr.) · 18601399559@163.com · +8618601399559
Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China
Contact: Study coordinator (Hai-Qing Luo, Dr.) · hqluo@126.com · +8613729196345

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC

Nasopharyngeal Cancinoma (NPC) · Nasopharangeal Cancer

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China · Shenzhen, China

Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC

Nasopharyngeal Cancinoma (NPC)

Abroad (travel likely)RecruitingPHASE3

Shanghai, China

Adaptive Immunotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Cancinoma (NPC)

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China

LDRT and Chemoimmunotherapy in NPC With Liver Metastasis

Nasopharyngeal Cancinoma (NPC)

Abroad (travel likely)RecruitingPHASE2

Changsha, China · Changsha, China